Mind Medicine (MNMD) has released an update.
Mind Medicine (MindMed) Inc., a biopharmaceutical company focusing on brain health disorders, has been included in the Russell 2000 and Russell 3000 indexes, marking a milestone that represents recognition of their efforts and potentially expanding their investor base. The inclusion means MindMed will be part of the large-cap or small-cap Russell indexes and also the growth and value style indexes, which are crucial for investment strategies and funds.
For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.
